Limited T cell receptor Vβ-chain repertoire of liver-infiltrating T cells in autoimmune hepatitis

Journal of Hepatology

Volumn 28, Issue 1, 1998, Pages 70-77

  Arenz, Monika ^a   Meyer Zum Büschenfelde, Karl Hermann ^a   Löhr, Hanns F ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Autoimmune hepatitis; Liver infiltrating T cells; RT PCR; T cell receptor

Indexed keywords

T LYMPHOCYTE RECEPTOR;

ADULT; AGED; ARTICLE; AUTOIMMUNE HEPATITIS; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; DENSITOMETRY; GENE OVEREXPRESSION; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREGULATION; LIVER TOXICITY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

EID: 0031888390     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(98)80204-3     Document Type: Article

References (30)

1. Meyer zum Büschenfelde K-H, Lohse AW, Manns M, Poralla T. Autoimmunity and liver disease. Hepatology. 12:1990;354-361.
2. Manns MP, Johnson EF, Griffin KJ, Tan EM, Sullivan KF. Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1. J Clin Invest. 83:1989;1066-1072.
3. Manns MP, Griffin KJ, Sullivan KF, Johnson EF. LKM-1 autoantibodies recognize a sort linear sequence in P450IID6, a cytochrome P-450 monooxygenase. J Clin Invest. 88:1991;1370-1378.
4. Löhr H, Treichel U, Poralla T, Manns M, Meyer zum Büschenfelde K-H, Fleischer B. The human asialoglycoprotein receptor (hASGPR) is a target antigen for liver-infiltrating T cells in autoimmune chronic active hepatitis and primary biliary cirrhosis. Hepatology. 12:1990;1314-1320.
5. Löhr H, Treichel U, Poralla T, Manns M, Meyer zum Büschenfelde K-H. Liver-infiltrating T helper cells in autoimmune chronic active hepatitis stimulate the production of autoantibodies against the human asialogycoprotein receptor in vitro. Clin Exp Immunol. 88:1992;45-49.
6. Marrack P, Kappler J. The T cell receptor. Science. 238:1987;1073-1079.
7. Acha-Orbea H, Mitchell DJ, Timmermann L, Wraith DC, Tausch GS, Waldor MK, et al. Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention. Cell. 54:1988;263-273.
8. Duby AD, Sinclair AK, Osborne LS, Zeldes W, Kan L, Fox DA. Clonal heterogeneity of synovial fluid T lymphocytes from patients with rheumatoid arthritis. Proc Natl Acad Sci USA. 86:1989;6206-6210.
9. Wucherpfennig KW, Ota K, Frido N, Seidman JG, Rosenzweig A, Weiner HL, et al. Shared human T cell Vβ usage to immunodominant regions of myelin basic protein. Science. 248:1990;1016-1019.
10. Kotzin BL, Karuturi S, Choi YK, Lafferty J, Forrester jM, Better M, et al. Preferential T-cell β-chain variable gene use in myelin basic protein-reactive T-cell clones from patients with multiple sclerosis. Proc Natl Acad Sci USA. 88:1991;9161-9165.
11. Uematsu Y, Wege H, Straus A, Ott M, Bannwarth W, Lanchbury J, et al. The T cell receptor repertoire is the synovial fluid of a patient with rheumatoid arthritis is polyclonal. Proc Natl Acad Sci USA. 88:1991;8534-8538.
12. Howell MD, Diveley JP, Lundeen KA, Esty A, Winters ST, Carlo DJ, et al. Limited T-cell receptor β-chain heterogeneity among interleukin-2 receptor positive synovial T cells suggests a role for superantigen in rheumatoid arthritis. Proc Natl Acad Sci USA. 88:1991;10921-10925.
13. Davies TF, Martin A, Concepcion ES, Lahat N, Cohen WL, Ben-Nun A. Evidence for selective accumulation of intrathyroidal T lymphocytes in human autoimmune thyroid disease based on T cell receptor V gene usage. J Clin Invest. 89:1992;157-162.
14. Hashim GA, Vandenbark AA, Galang AB. Antibodies specific for Vβ8 receptor peptide suppress experimental autoimmune encephalomyelitis. J Immunol. 144:1990;4621-4627.
15. Vandenbark AA, Hashim G, Offner H. Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis. Nature. 341:1989;541-544.
16. Moebius U, Manns M, Hess G, Kober G, Meyer zum Büschenfelde K-H, Meuer SC. T cell receptor gene rearrangement of T lymphocytes infiltrating the liver in chronic active hepatitis B and primary biliary cirrhosis (PBC): oligoclonality of PBC-derived T cell clones. Eur J Immunol. 20:1990;889-8896.
17. Hoshino Y, Enomoto N, Izumi N, Kurosaki M, Marumo F, Sato C. Limited usage of T-cell receptor β-chains and sequences of the complementary determining region 3 of lymphocytes infiltrating in the liver of autoimmune hepatitis. Hepatology. 22:1995;142-147.
18. Broome U, Grunewald J, Scheynius A, Olerup O, Hultcrantz R. Preferential Vβ3 usage by hepatic T lymphocytes in patients with primary sclerosing cholangitis. J Hepatol. 26:1997;527-534.
19. Reddy KR, Krawitt EL, Homberg JC, Jeffers LJ, de Medina M, Chastenay B, et al. Absence of anti-LKM-1 antibody in hepatitis C viral infection in the United States of America. J Viral Hepatitis. 1995;175-179.
20. Arenz M, Meyer zum Büschenfelde K-H, Löhr HF. Antigen-independent in vitro T cell expansion does not influence the T cell receptor Vβ-repertoire. Approach to characterize small organ-infiltrating T cell populations. J Mol Med; in press.
21. Choi Y, Kotzin B, Herron L, Callahan J, Marrack P, Kappler J. Interaction of Staphylococcus aureus toxin "superantigens" with human T cells. Proc Natl Acad Sci USA. 86:1989;8941-8945.
22. Genevee C, Diu A, Nierat J, Caingard A, Dietrich P, Ferradini L, et al. An experimentally validated panel of subfamily specific olignoucleotide primers (Vα1-w79/Vβ1-w24) for the study of human T cell receptor variable V gene segment usage by polymerase chain reaction. Eur J Immunol. 22:1992;1261-1269.
23. Paliard X, West SG, Lafferty JA, Clements JR, Kappler JW, Marrack P, et al. Evidence for the effects of a superantigen in rheumatoid arthritis. Science. 253:1991;325-329.
24. Weidmann E, Whiteside TL, Giorda R, Herberman RB, Trucco M. The T-cell receptor Vβ gene usage in tumor-infiltrating lymphocytes and blood of patients with hepatocellular carcinoma. Cancer Res. 52:1992;5913-5920.
25. Sensi M, Parmi G. Analysis of TCR usage in human tumors: a new tool for assessing tumor-specific immune responses. Immunol Today. 16:1996;588-595.
26. Ferradini L, Mackensen A, Genevee C, Bosq J, Duvillard P, Avril M-F, et al. Analysis of T cell receptor variability in tumor-infiltrating lymphocytes from a human regressive melanoma. J Clin Invest. 91:1993;1183-1190.
27. Jason J, Inge KL. The effects of mitogens, IL-2 and anti-CD3 antibody on the T cell receptor Vβ-repertoire. Scand J Immunol. 43:1996;652-661.
28. Kashii Y, Shimizu Y, Nambu S, Minemura M, Okada K, Kiyohiro H, et al. Analysis of T cell receptor Vβ repertoire in liver-infiltrating lymphocytes in chronic hepatitis C. J Hepatol. 26:1997;462-470.
29. Löhr H, Manns M, Kyriatsoulis A, Lohse AW, Trautwein C, Meyer zum Büschenfelde KH, et al. Clonal analysis of liver-infiltrating T cells in patients with LKM-1 antibody-positive autoimmune chronic active hepatitis. Clin Exp Immunol. 84:1991;297-302.
30. Löhr HF, Schlaak JF, Lohse AW, Böcher WO, Arenz M, Gerken G, Meyer zum Büschenfelde KH. Autoreactive CD4+ LKM-specific and anticlonotypic T-cell responses in LKM-1 antibody-positive autoimmune hepatitis. Hepatology. 24:1996;1416-1421.